Coastal Bridge Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.52M | Buy |
+30,399
| New | +$2.52M | 0.21% | 113 |
|
|
2025
Q1 | – | Sell |
-13,166
| Closed | -$1.19M | – | 405 |
|
|
2024
Q4 | $1.19M | Sell |
13,166
-927
| -7% | -$83.5K | 0.3% | 61 |
|
|
2024
Q3 | $1.39M | Sell |
14,093
-325
| -2% | -$32.1K | 0.35% | 53 |
|
|
2024
Q2 | $1.34M | Sell |
14,418
-78
| -0.5% | -$7.23K | 0.33% | 53 |
|
|
2024
Q1 | $1.38M | Sell |
14,496
-536
| -4% | -$50.9K | 0.32% | 53 |
|
|
2023
Q4 | $1.34M | Sell |
15,032
-9,394
| -38% | -$839K | 0.34% | 50 |
|
|
2023
Q3 | $1.78M | Hold |
24,426
| – | – | 0.48% | 36 |
|
|
2023
Q2 | $2.03M | Sell |
24,426
-753
| -3% | -$62.7K | 0.5% | 36 |
|
|
2023
Q1 | $1.92M | Sell |
25,179
-331
| -1% | -$25.2K | 0.49% | 38 |
|
|
2022
Q4 | $2.12M | Sell |
25,510
-3,690
| -13% | -$306K | 0.6% | 34 |
|
|
2022
Q3 | $2.32M | Buy |
29,200
+1,556
| +6% | +$123K | 0.62% | 34 |
|
|
2022
Q2 | $2.05M | Buy |
27,644
+3,487
| +14% | +$259K | 0.63% | 34 |
|
|
2022
Q1 | $2.17M | Buy |
24,157
+11,049
| +84% | +$993K | 0.5% | 36 |
|
|
2021
Q4 | $1.55M | Buy |
13,108
+1,801
| +16% | +$213K | 0.32% | 50 |
|
|
2021
Q3 | $1.42M | Buy |
11,307
+38
| +0.3% | +$4.78K | 0.33% | 46 |
|
|
2021
Q2 | $1.53M | Buy |
11,269
+3,690
| +49% | +$500K | 0.31% | 46 |
|
|
2021
Q1 | $1.03M | Buy |
7,579
+4,586
| +153% | +$622K | 0.19% | 53 |
|
|
2020
Q4 | $421K | Buy |
+2,993
| New | +$421K | 0.08% | 81 |
|